Espinoza, L.C.; Vera-GarcÃa, R.; Silva-Abreu, M.; Domènech, Ã’.; Badia, J.; RodrÃguez-Lagunas, M.J.; Clares, B.; Calpena, A.C.
Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model. Pharmaceutics 2020, 12, 255.
https://doi.org/10.3390/pharmaceutics12030255
AMA Style
Espinoza LC, Vera-GarcÃa R, Silva-Abreu M, Domènech Ã’, Badia J, RodrÃguez-Lagunas MJ, Clares B, Calpena AC.
Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model. Pharmaceutics. 2020; 12(3):255.
https://doi.org/10.3390/pharmaceutics12030255
Chicago/Turabian Style
Espinoza, Lupe Carolina, Rodrigo Vera-GarcÃa, Marcelle Silva-Abreu, Ã’scar Domènech, Josefa Badia, MarÃa J. RodrÃguez-Lagunas, Beatriz Clares, and Ana Cristina Calpena.
2020. "Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model" Pharmaceutics 12, no. 3: 255.
https://doi.org/10.3390/pharmaceutics12030255
APA Style
Espinoza, L. C., Vera-GarcÃa, R., Silva-Abreu, M., Domènech, Ã’., Badia, J., RodrÃguez-Lagunas, M. J., Clares, B., & Calpena, A. C.
(2020). Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model. Pharmaceutics, 12(3), 255.
https://doi.org/10.3390/pharmaceutics12030255